Nephrology

RSS

Glaxo Wellcome describes alpha1A-adrenoceptor antagonists

July 19, 1996

Cystistat covered under U.S. patent

July 12, 1996

5alpha-Reductase inhibitors from Kyowa Hakko

July 12, 1996

Selective alpha1A-adrenoceptor antagonists with multiple indications

July 12, 1996

Flutamide BPH trial results reported

July 5, 1996

Abbott reports alpha1-antagonists for BPH

July 5, 1996

Human Genome Sciences discloses polypeptide research

June 28, 1996

Generic triamterene/hydrochlorothiazide approved by FDA

June 28, 1996

GelTex's RenaGel enters phase III

June 21, 1996

NS-21 licensing options awarded

June 21, 1996